Checkpoint Inhibitors and Associated Rheumatic Disease_19th LMLR

preview_player
Показать описание
Speakers: Dr. Dennis Lee Sacdalan & Dr. Anna Kristina Rubio
Moderator: Dr. Evelyn Salido
  1. PGH Division of Rheumatology
Рекомендации по теме
Checkpoint Inhibitors and 1:19:41

Checkpoint Inhibitors and Associated Rheumatic Disease_19th LMLR

“Rheumatologic Consequences of 1:02:47

“Rheumatologic Consequences of Immune Checkpoint Inhibitors”, Annual Kessler Lecture, Dr. Ami Shah...

Rheumatic and musculoskeletal 0:04:06

Rheumatic and musculoskeletal adverse events with immune checkpoint inhibitors

Targeting the immune 0:27:43

Targeting the immune system with checkpoint inhibitors

Checkpoint inhibitors: monitoring 0:05:26

Checkpoint inhibitors: monitoring and management of imAEs - video abstract ID 141577

Immune-related adverse events 0:13:16

Immune-related adverse events due to checkpoint inhibitors

Managing toxicities associated 0:14:42

Managing toxicities associated with immune-checkpoint inhibitors

Anne Bass, MD: 0:02:03

Anne Bass, MD: Immune Checkpoint Inhibitors in Rheumatic Disease

Immune Checkpoint Inhibitor 0:55:56

Immune Checkpoint Inhibitor Toxicities in the ICU: A review - SJHH Medical Grand Rounds

iRAEs, Treatments for 0:05:58

iRAEs, Treatments for Checkpoint Inhibitor Inflammatory Arthritis and PMR

Medicine Grand Rounds: 0:58:19

Medicine Grand Rounds: Rheumatology 2/27/18

Dr. Mohammed Algarni. 0:20:10

Dr. Mohammed Algarni. Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors

Keynote Lecture: Managing 0:31:15

Keynote Lecture: Managing Side Effects of IO Agents

Monitoring, managing, and 0:21:59

Monitoring, managing, and mitigating immune-related adverse events

Immunotherapy: Checkpoint Inhibitors 0:01:00

Immunotherapy: Checkpoint Inhibitors

Immune Checkpoint Inhibitors: 1:01:45

Immune Checkpoint Inhibitors: The Good, the Bad, and the Emerging Field of Cardio-Oncology

Panel Presentation: Understanding 0:05:24

Panel Presentation: Understanding iRAEs from Immune Checkpoint Inhibitors

New Checkpoint Inhibitors 0:23:20

New Checkpoint Inhibitors & Immunotherapy in Metastatic Melanoma - Michael Postow MD

HSS Minute: Adverse 0:01:02

HSS Minute: Adverse Event Management for Checkpoint Inhibitors

Efficacy of immune 0:00:26

Efficacy of immune checkpoint inhibitors in different types of melanoma | RTCL.TV

Is there a 0:00:24

Is there a role for therapeutic cancer vaccines in the age of checkpoint inhibitors? | RTCL.TV

Inflammatory Arthritis Persists 0:01:30

Inflammatory Arthritis Persists After Immunotherapy Cessation: Dr. David Liew

Dr. Cassandra Calabrese 0:01:10

Dr. Cassandra Calabrese on Checkpoint Inhibitors at ACR 2018

Understanding Inflammatory Arthritis 0:02:15

Understanding Inflammatory Arthritis in Cancer Patients Caused by Checkpoint Inhibitors